4Cayre A, Cachin F, Maublant J, et al. Single static view ^99mTc sestamibi scinti-mammography predicts response to neoadjuvant chemotherapy and is related to MDR expression [ J ]. Int J Oncol,2002,20(5 ) : 1049-1055.
5Alassas M, Chu Q, Burton G, et al.Neoadjuvant chemotherapy in stage Ⅲ breast cancer[J]. Am Surg,2005,71 (6) :487-492.
6Steven D Heys,Tarun Sarkar,Andrew W Hutcheon,et al.Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer[J].Expert Opinion on Pharmacotherapy,2004,5(10):2147-2157.
7Citron ML,Berry DA,Cirrineione C,et a1.Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 974l[J].J Clin Oncol,2003,21(8):1431-1439.
8Early Breast Cancer Trialists' Collaborative Group.Tamoxifen for early breast cancer:an overview of the randomized trials[C].Lancet,1998,351:1451.
9Coombes RC,Hall E,Gibson LJ,et al.A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer[J].N Engl J Med,2004,350:1081.
10Baum M,Buzdar AU,Cuzik J,et al.Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer:first results of the ATAC randomised trial[J].Lancet,2002,359:2131.
